U.S. Paper and Forestry Products Stock News

NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Diodes (DIOD) Is Up 20.7% After Strong Q4 Results, Buybacks And Upbeat Q1 2026 Guidance

In February 2026, Diodes Incorporated reported fourth-quarter 2025 results showing higher sales and earnings year-over-year, outlined full-year growth in revenue and net income, completed a share repurchase of 720,485 shares for US$33.81 million, and issued first-quarter 2026 revenue guidance of about US$395 million, plus or minus 3%, indicating better-than-usual seasonality. Management also introduced three-year interim financial targets, including aspiring to reach US$2 billion in annual...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Biosciences Enters New Growth Phase With Broader Revenue Mix

Neurocrine Biosciences (NasdaqGS:NBIX) is rolling out new products, including Chronesity and CRENESSITY, alongside a broad set of pipeline updates. The company reports strong early adoption for both launches, with CRENESSITY expected to reach blockbuster levels over time. Late stage clinical programs in neuropsychiatry and metabolic diseases are expanding, supported by a build out of the sales force and commercial capabilities. For you as an investor, the key point is that Neurocrine...
NasdaqGM:PSNY
NasdaqGM:PSNYAuto

A Look At Polestar Automotive Holding UK (NasdaqGM:PSNY) Valuation After Its US$400m Private Placement Announcement

Private placement draws fresh attention to Polestar Automotive Holding UK (NasdaqGM:PSNY) Polestar Automotive Holding UK (NasdaqGM:PSNY) has agreed to a private placement of over 20,682,000 new Class A American Depositary Shares, raising about US$400m from entities linked to Sumitomo Mitsui Banking Corporation and Standard Chartered. The deal is priced at US$19.34 per share and is expected to close by February 5, 2026. It brings in institutional capital while keeping each new investor below a...
NYSE:CRL
NYSE:CRLLife Sciences

Charles River Labs Quarterly Resilience Faces Declining Organic Revenue Test

Charles River Laboratories International (NYSE:CRL) has reported resilient quarterly results, with recent figures holding up despite pressures in its core operations. The company is working through a decline in organic revenue and facing ongoing challenges in its key business lines. Analysts expect only modest revenue growth ahead, while return on invested capital is trending lower, pointing to fewer highly profitable projects. For investors tracking NYSE:CRL, the share price of $158.74...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog Q4 AI Bookings And Bits AI Put Growth Versus Margins In Focus

Datadog (NasdaqGS:DDOG) reported strong Q4 results with record AI driven bookings. The company introduced Bits AI, an autonomous DevOps assistant aimed at incident management and coding workflows. Datadog also outlined progress toward FedRAMP High compliance, targeting greater access to US federal contracts from 2026. Datadog, best known for its cloud based observability and security platform, is leaning heavily into AI as customers look for tools that cut noise and automate routine work...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal CEO Shift And AI Travel Push Raise Questions For Undervalued Shares

PayPal Holdings (NasdaqGS:PYPL) appoints Enrique Lores as CEO and President following the abrupt departure of Alex Chriss. The leadership change comes as the company addresses execution challenges and rising competition in digital payments. PayPal also announces a new partnership with Sabre and Mindtrip to power an AI based travel booking experience that integrates its digital wallet. For you as an investor, these moves come at a time when digital payments are tightly linked to e commerce,...
NYSE:RYAN
NYSE:RYANInsurance

Ryan Specialty Reshapes Canada Operations As Cash Returns Take Center Stage

Ryan Specialty Holdings (NYSE:RYAN) has created Ryan Specialty Canada Limited, combining several Canadian managing general underwriters into one platform. Stephen Stewart has been appointed CEO of the unified Canadian business as part of a broader restructuring of the company’s operations in Canada. The board has approved a $300 million share repurchase program alongside an increase to the quarterly dividend. These steps follow a period of acquisition driven expansion and ongoing integration...
NYSE:LEN
NYSE:LENConsumer Durables

Is Lennar’s Aggressive New‑Home Price Cutting Amid Affordability Crunch Altering The Investment Case For Lennar (LEN)?

Recently, Lennar's CEO highlighted that homebuilders have been cutting new-home prices more aggressively than individual sellers as the US housing market remains mired in an affordability crisis, with nearly one-fifth of new listings seeing price reductions in late 2025. This shift toward a buyer's market not only pressures builders' pricing power but also signals how far companies like Lennar are willing to adjust to keep sales volumes moving. We'll now examine how Lennar's aggressive...